VIR-5500

AMX-500 · Vir Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIR-5500, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer [Phase 1]